Clinical Trials List
Protocol NumberSQZ-AAC-HPV-101
2022-06-01 - 2022-12-27
Phase I
Recruiting3
-
Trial Applicant
ICON Clinical Research Pte Ltd
-
Sponsor
-
Trial scale
Multi-Regional Multi-Center
-
Update
2025/08/20
Investigators and Locations
Co-Principal Investigator
- Wen-Fang Cheng Division of Obstetrics & Gynecology
- HUAI-CHENG HUANG Division of Hematology & Oncology
- 徐偉勛 醫學研究部
- Hsiang-Fong Kao Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Co-Principal Investigator
- Yu-Min Liao Division of Hematology & Oncology
- Li-Yuan Bai Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
The Actual Total Number of Participants Enrolled
0 Recruiting
Condition/Disease
Objectives
Test Drug
Active Ingredient
Dosage Form
Dosage
Endpoints
Inclution Criteria
The Estimated Number of Participants
-
Taiwan
12 participants
-
Global
72 participants
